Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,950 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in China.
Gao Y, Liu Y, Wang Y, Zhang Q, Wu D, Ye X, Wu J, Xu W, Zhou J, Yang Y, Cen H, Zhang F, Xiang Y, Tang X, Ding K, Lin J, Ma L, Wang S, Yu H, Zhao Y, Song B, Lv F, Huang H. Gao Y, et al. Among authors: ding k. Cancer. 2023 Feb 15;129(4):551-559. doi: 10.1002/cncr.34544. Epub 2022 Dec 21. Cancer. 2023. PMID: 36541221 Free article.
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.
Shi Y, Jia B, Xu W, Li W, Liu T, Liu P, Zhao W, Zhang H, Sun X, Yang H, Zhang X, Jin J, Jin Z, Li Z, Qiu L, Dong M, Huang X, Luo Y, Wang X, Wang X, Wu J, Xu J, Yi P, Zhou J, He H, Liu L, Shen J, Tang X, Wang J, Yang J, Zeng Q, Zhang Z, Cai Z, Chen X, Ding K, Hou M, Huang H, Li X, Liang R, Liu Q, Song Y, Su H, Gao Y, Liu L, Luo J, Su L, Sun Z, Tan H, Wang H, Wang J, Wang S, Zhang H, Zhang X, Zhou D, Bai O, Wu G, Zhang L, Zhang Y. Shi Y, et al. Among authors: ding k. J Hematol Oncol. 2017 Mar 15;10(1):69. doi: 10.1186/s13045-017-0439-6. J Hematol Oncol. 2017. PMID: 28298231 Free PMC article.
YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial.
Liu W, Li Y, Wang Q, Su H, Ding K, Shuang Y, Gao S, Zou D, Jing H, Chai Y, Zhang Y, Liu L, Wang C, Liu H, Lin J, Zhu H, Yao C, Yan X, Shang M, Wang S, Chang F, Wang X, Zhu J, Song Y. Liu W, et al. Among authors: ding k. Front Med (Lausanne). 2021 Feb 2;8:609116. doi: 10.3389/fmed.2021.609116. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33604348 Free PMC article.
Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China.
Zha J, Fan L, Yi S, Yu H, Zheng Z, Xu W, Deng M, Lin Z, Li Z, Ping L, He X, Chen F, Xie Y, Chen B, Zhang H, Wang L, Ding K, Li W, Yang H, Zhao W, Qiu L, Li Z, Song Y, Xu B. Zha J, et al. Among authors: ding k. J Hematol Oncol. 2021 Aug 23;14(1):131. doi: 10.1186/s13045-021-01139-6. J Hematol Oncol. 2021. PMID: 34425858 Free PMC article.
[The efficacy and safety profile of ixazomib/lenalidomide/dexamethasone in relapsed/refractory multiple myeloma: a multicenter real-world study in China].
Yang Y, Xia ZJ, Zhang WH, Fu CC, Bao L, Chen B, Ding KY, Wang SL, Luo J, Li BZ, Hua LM, Yang W, Zhou X, Wang L, Xu TH, Wang WD, Wu GL, Huang Y, Li J, Liu P. Yang Y, et al. Among authors: ding ky. Zhonghua Xue Ye Xue Za Zhi. 2021 Aug 14;42(8):628-634. doi: 10.3760/cma.j.issn.0253-2727.2021.08.003. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34547867 Free PMC article. Chinese.
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China.
Liu W, Zhao D, Liu T, Niu T, Song Y, Xu W, Jin J, Cai Q, Huang H, Li Z, Hou M, Zhang H, Zhou J, Hu J, Shen J, Shi Y, Yang Y, Zhang L, Zhao W, Ding K, Qiu L, Tan H, Zhang Z, Liu L, Wang J, Xu B, Zhou H, Gao G, Xue H, Bai O, Feng R, Huang X, Yang H, Yan X, Zeng Q, Liu P, Li W, Mao M, Su H, Wang X, Xu J, Zhou D, Zhang H, Ma J, Shen Z, Zhu J. Liu W, et al. Among authors: ding k. Front Oncol. 2021 Nov 4;11:750323. doi: 10.3389/fonc.2021.750323. eCollection 2021. Front Oncol. 2021. PMID: 34804937 Free PMC article.
[Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma].
Song J, Liu H, Shen HL, Yue LZ, Yang XJ, Song WJ, Sun CY, Yu SZ, Ding K, Wang YH, Li LJ, Yu H, Shao YY, Wang CM, Yue SY, Fu R. Song J, et al. Among authors: ding k. Zhonghua Xue Ye Xue Za Zhi. 2021 Nov 14;42(11):917-922. doi: 10.3760/cma.j.issn.0253-2727.2021.11.006. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 35045653 Free PMC article. Chinese.
Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201).
Song Y, Zhou K, Jin C, Qian Z, Hou M, Fan L, Li F, Ding K, Zhou H, Li X, Chen B, Sun X, Song X, Jiang M, Zhang Q, Liu L, Yu G, Hu Y, Zhao Z, Liu L, Xue H, Luo J, He B, Jin X, Zhao M, Li B, Xia Y, Zhu J. Song Y, et al. Among authors: ding k. Front Oncol. 2022 Jul 7;12:925236. doi: 10.3389/fonc.2022.925236. eCollection 2022. Front Oncol. 2022. PMID: 35875118 Free PMC article.
[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component].
Lin ZJ, Zha J, Yi SH, Li ZF, Ping LY, He XH, Yu HF, Zheng Z, Xu W, Chen FL, Xie Y, Chen BY, Zhang HL, Wang L, Ding KY, Li WY, Yang HY, Zhao WL, Qiu LG, Li ZM, Song YQ, Xu B. Lin ZJ, et al. Among authors: ding ky. Zhonghua Xue Ye Xue Za Zhi. 2022 Jun 14;43(6):456-462. doi: 10.3760/cma.j.issn.0253-2727.2022.06.003. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35968587 Free PMC article. Chinese.
2,950 results